Workflow
Tilray(TLRY)
icon
Search documents
Tilray Medical Brings Canada’s Iconic Cannabis Brand Good Supply to Germany
Globenewswire· 2025-05-22 11:00
Core Insights - Tilray Medical has launched its cannabis brand Good Supply in Germany, aiming to provide affordable and reliable medical cannabis options for patients [1][2][3] - The introduction of Good Supply reflects Tilray's commitment to enhancing patient care and empowering healthcare professionals with innovative medical cannabis solutions [2][3] - Good Supply offers a variety of cannabis strains, available in both 15g and 500g, catering to the diverse needs of patients [2][7] Company Overview - Tilray Medical is a leading player in the global medical cannabis industry, with operations in Canada, Portugal, and Germany, and is recognized for its commitment to quality and innovation [3][4] - The company has established itself as a trusted supplier of medical cannabis, with a portfolio that includes multiple brands designed to meet patient needs worldwide [4][6] - Tilray Brands, Inc. operates as a global lifestyle and consumer packaged goods company, focusing on cannabis, wellness, and entertainment, with a mission to inspire joy and create memorable experiences [6]
Tilray Brands Announces the Launch of XMG Atomic Sours: New THC Beverages and Edibles
GlobeNewswire News Room· 2025-05-14 11:00
TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, is excited to announce that its wholly-owned subsidiary, High Park Holdings Ltd., is launching XMG Atomic Sours, a new line of cannabis beverages and gummies that redefine the sour experience. XMG Atomic Sours includes two cannabis-infused drinks, Cherry Blasted Lime and Foggy Peaches, and two cannabis- ...
Best Canadian Marijuana Stocks for U.S. Market Exposure
Marijuana Stocks | Cannabis Investments And News. Roots Of A Budding Industry.™· 2025-05-13 14:00
The U.S. cannabis industry continues to surge, reaching an estimated $45 billion in 2025. Analysts expect it to grow to over $75 billion by 2030. With federal reform discussions advancing and legalization expanding, Canadian cannabis companies are positioning for growth. Many are making strategic moves to increase their U.S. exposure through acquisitions and partnerships. Canadian Cannabis Stocks With U.S. Growth Potential This momentum has sparked investor interest in Canadian companies with operational ti ...
2 Stocks Near Their 52-Week Lows That Still Aren't Worth Buying
The Motley Fool· 2025-05-13 08:14
1. Tilray Brands Tilray Brands, a leader in the cannabis industry, recently announced a proposal to execute a reverse stock split. Forward stock splits are usually a sign that a company is performing well. For reverse ones, they often signal a company has performed terribly and now has a share price below $1. That's the case with Tilray. It hopes this move will raise its stock price above $1 and help in its efforts to avoid delisting from the Nasdaq stock exchange. But a reverse split will not change the co ...
Top 3 Marijuana Stocks For Better Investing 2025
Marijuana Stocks | Cannabis Investments And News. Roots Of A Budding Industry.™· 2025-05-09 13:10
Industry Overview - The current state of marijuana stocks is characterized by a downtrend due to the lack of federal reform, tax relief, and improved banking access, leading to volatility in trading [1] - Despite over half of the US and other global regions legalizing cannabis, market saturation and taxation challenges persist, causing investors to remain cautious [2] - The cannabis stock market has seen significant price drops, presenting opportunities for investors to buy shares at lower prices, with some multi-state operators (MSOs) reporting substantial revenue growth [3] Company Highlights - **Tilray Brands, Inc.**: Engages in the research, cultivation, processing, and distribution of medical cannabis products across multiple regions including Canada and the US. Recently announced the re-release of Delayed Pilsner, aimed at providing comfort to consumers [4][6] - **Cronos Group Inc.**: Focuses on the cultivation, production, distribution, and marketing of cannabis products in Canada and internationally. Scheduled a virtual annual meeting for shareholders on June 20, 2025 [7][10] - **Village Farms International, Inc.**: Produces and markets greenhouse-grown vegetables and is planning to reschedule its Q1 conference call for May 13, 2025 [12]
1 Beaten-Down Stock-Split Company to Avoid in 2025 and Beyond
The Motley Fool· 2025-05-09 08:30
Core Viewpoint - Stock splits can indicate a company's performance, with forward splits often seen positively, while reverse splits may signal struggles, as exemplified by Tilray Brands [1][2][4]. Group 1: Stock Splits - A forward stock split increases the number of shares for each investor, often indicating expected strong performance and making shares more affordable [2]. - A reverse stock split reduces the number of shares and increases the stock price proportionately, often used to avoid delisting from major exchanges [2][3]. Group 2: Tilray's Performance - Tilray has faced significant challenges, with its share price dropping below $1, currently at approximately $0.43, indicating a long-term downward trend [4]. - The company's financial results are disappointing, with revenue growth largely driven by acquisitions and consistent unprofitability [4][6]. - The legal landscape for cannabis remains difficult, with federal illegality in the U.S. and regulatory barriers in Canada hindering growth [6]. Group 3: Reverse Stock Split Proposal - Tilray announced a special stockholders' meeting to vote on a reverse stock split proposal, which is likely to be approved given the company's current situation [7]. - A reverse stock split would prevent delisting from Nasdaq but does not address the underlying business challenges [8]. Group 4: Future Prospects - Tilray has reduced its focus on cannabis and is now a leading craft brewer in the U.S., hoping for future federal legalization of cannabis [8]. - CEO Irwin Simon anticipates potential legalization during President Trump's second term, which could position Tilray favorably in the cannabis-infused drinks market [9]. - However, uncertainties remain regarding the timeline and specifics of legalization, which could limit market potential [9][10]. Group 5: Investment Outlook - Given the ongoing challenges and lack of attractive business prospects, Tilray is not considered an appealing investment opportunity [10].
Shock Top: A Bold Rebrand for a Craft Beer Icon
Globenewswire· 2025-05-08 11:00
Core Viewpoint - Shock Top, a craft beer brand under Tilray Brands, Inc., is undergoing a significant rebranding effort to attract a new generation of beer drinkers with modern packaging, a new logo, and an integrated marketing campaign [1][5]. Group 1: Rebranding and Marketing Strategy - The rebrand introduces a new visual identity featuring the Wedgehead icon, designed to be bolder and more contemporary, symbolizing an uplifting experience [2]. - Shock Top's beer lineup will be refreshed, starting with the Belgian White and including seasonal favorites like Cosmic Berry and Lemonade Shandy, all featuring vibrant visuals [4]. - The marketing strategy includes digital media investments, partnerships with universities, and in-stadium experiences to engage new consumers [5][6]. Group 2: Market Positioning - The rebranding comes at a time when consumers are leaning towards above-premium options, positioning Shock Top to appeal to both loyal fans and new drinkers seeking unique flavors [5]. - The brand aims to grow its market share by embracing unexpected flavors and experiences, aligning with current consumer trends [5]. Group 3: Company Background - Shock Top was founded in 2006 with the launch of its Belgian White Ale and is known for its bold flavors and fun approach to brewing [7]. - Tilray Brands, Inc. operates globally in the lifestyle and consumer packaged goods sector, focusing on innovative products that create memorable experiences [8].
Tilray Brands Stock Is Trading at Its All-Time Low. Is It Worth Buying?
The Motley Fool· 2025-05-08 09:31
Core Viewpoint - Tilray Brands is currently trading at its all-time low, having lost 94% of its value over the past five years, primarily due to the lack of marijuana legalization in the U.S. which investors had anticipated [1][4][10] Financial Performance - The company's total net revenue for the most recent quarter ended on February 28 was $185.8 million, reflecting a 1% decline [7] - Tilray reported an operating loss of $760 million, which included impairment charges of nearly $700 million [7] - The company burned through $5.8 million in cash from its day-to-day operations [7] Growth Strategy - Tilray has been pivoting towards alcohol to grow its top line, but this strategy has not generated sufficient growth to attract investors [5][6] - The company is exploring international cannabis markets and acquiring craft beer brands in the U.S. as potential growth avenues, but these efforts have not yielded significant results [6] Investment Considerations - The stock has been in a continuous decline, and buying it at a lower price has not proven to be a successful strategy [9] - Without a significant catalyst for growth or a clear path to profitability, the stock may not be a worthwhile investment at this time [10]
Blue Point Brewing Co. Announces the Return of Delayed Pilsner
Globenewswire· 2025-05-06 11:00
Core Insights - Blue Point Brewing Co. has re-released Delayed Pilsner, a craft beer aimed at alleviating the frustrations of delays experienced by New Yorkers [1][4] - The beer features a blend of floral and spicy hops, with apple and lemon-lime aromas, balanced by honey notes from a creamy malt body, resulting in a crisp lager [2][4] - Delayed Pilsner is available in 16oz cans at transit hubs and select retailers throughout the Metro New York area [4] Company Overview - Blue Point Brewing Company, founded in 1998 in Patchogue, New York, is recognized as Long Island's original craft brewery and has grown to be one of the largest breweries in New York [7] - The brewery has a diverse portfolio of beer brands, with its flagship Toasted Lager winning multiple awards, including a gold medal at the World Beer Cup [7] - Blue Point Brewing is part of Tilray Brands, Inc., a global lifestyle and consumer packaged goods company with operations across various regions, including North America and Europe [9]
Why Tilray Stock Plummeted by 26% in April
The Motley Fool· 2025-05-03 12:56
Core Insights - The marijuana sector continues to face significant challenges, leading to a lack of investor interest, particularly as cannabis remains illegal at the federal level in the U.S. [1] - Tilray Brands has experienced a substantial decline in its stock value, losing over 26% in April and trading under $1, indicating a prolonged downward trend [1][4] - The company reported a 1% year-over-year decline in net revenue for fiscal Q3 2025, totaling just under $186 million, and posted a non-GAAP loss of $2.9 million compared to a profit of $885,000 in the same period the previous year [2][4] Financial Performance - Tilray's management has reduced its revenue guidance for 2025, now expecting $850 million to $900 million, down from a previous estimate of $950 million to $1 billion [4] - The company is considering a reverse stock split with a proposed ratio of 1-to-10 to 1-to-20 to boost its stock price, which will be voted on in a special shareholders' meeting on June 10 [5] Diversification Efforts - In an attempt to diversify, Tilray has been acquiring craft breweries, as beer has broader market appeal and is not subject to the same regulatory challenges as cannabis [7] - However, the beer market has also faced challenges, with consumption hitting a four-decade low in 2024, raising doubts about whether this strategy will improve Tilray's fortunes [8] Market Outlook - There are currently no clear catalysts for Tilray's recovery, with the only potential being the decriminalization of cannabis in the U.S., which appears unlikely in the near term [9]